AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Sunshine Biopharma Inc. Director's Dealing 2021

Dec 9, 2021

35352_dirs_2021-12-09_31480863-b44f-4c01-8b38-9cb7dd9abd36.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Sunshine Biopharma, Inc (SBFM)
CIK: 0001402328
Period of Report: 2021-10-31

Reporting Person: TELSEY ANDREW I (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3000	Direct